Skip to main content
Chapters 38 total chapters

NEET UG · Biology

Biotechnology and its applications

Revise the concepts. Try a question. Understand your next step.

96 medium questions available · Try answers free. Sign in to save progress or take a quiz.

NEET UG · Biology

Continue studying Biotechnology And Its Applications

Understand the concept, practise questions and check your learning.

Understand

Distinguish Bt protein action, RNA-guided silencing and precursor processing while separating DNA evidence from functional protein outcomes. Biotechnology applications: trace the molecule and its consequence

About 6 min · NEET UG

Read the guide

Practise

Try 96 medium chapter MCQs. Untimed; check answers and available explanations as you go.

Free answers · Sign in to save progress

Practise chapter MCQs

Check your learning

Prepare a timed chapter quiz. Choose the available question count and pace before starting.

Sign-in required · Explanations after submission

Prepare a chapter quiz

This is chapter practice, not a full-length NEET mock paper.

Choose your practice

All Biology chapters →

These are playable question counts after quality and duplicate checks.

How practice and quizzes work

The practice player uses single-correct-answer MCQs. Chapter quizzes are not full-length NEET mock papers. Check the practice guide and official syllabus sources.

Revise before you practise

Study resources 63

Open full resource hub →

Biotechnology applications: trace the molecule and its consequence

Distinguish Bt protein action, RNA-guided silencing and precursor processing while separating DNA evidence from functional protein outcomes.

What you will understand

For NEET UG Biology students: identify the molecule that acts, distinguish target-RNA silencing from protein action and explain why a precursor account differs from a finished protein.

Jump to chapter practice →

Quick answer: the intervention and its product act at a specific level

A DNA construct can support production of a protein or an RNA with a particular effect. In the relevant Bt example, a Cry protein acts in a susceptible target context. In a target-RNA cleavage example, an RNA-guided silencing pathway reduces a messenger RNA and its protein output. Neither description alone means that the target DNA sequence has been deleted.

Compare a protein route with one RNAi route

The first conceptual route connects gene expression to Cry protein, interaction with a susceptible target insect gut and target-cell effects. Its specificity depends on the protein and target organism; it is not a universal insect-killing claim. The second represents one RNA-interference cleavage pathway: double-stranded RNA yields a guide-containing silencing complex, target messenger RNA is cleaved and target protein production decreases. Intermediate processing steps and other silencing mechanisms are omitted. RNA silencing here does not require deletion of target DNA, and an RNA guide is not itself a protein toxin.
The upper route connects gene expression to Cry protein and effects in a susceptible target insect gut. Which protein and target organism are involved matters. The lower route follows dsRNA to a guide-containing complex, target mRNA cleavage and less target protein. It represents one silencing mechanism; intermediate processing steps and other RNAi effects are omitted. A silencing RNA is not itself a protein toxin.

Open full-size diagram ↗

Locate the unsupported DNA-deletion conclusion

An original description gives reduced target mRNA and protein after a complementary RNA-silencing intervention. It then claims that the target gene must have been cut out of the genome. That conclusion does not follow: target-RNA reduction can occur while the DNA remains present. The observation concerns expression at the RNA/protein level, so DNA alteration would need its own evidence.

Target specificity matters in the Bt account

Cry proteins differ in the organisms and physiological contexts in which they act. The textbook route includes ingestion and activity in a susceptible insect gut, rather than an assertion that every Cry protein acts equally on all insects. A crop label or one organism’s response does not by itself establish universal activity against unrelated targets.

Separate a precursor from the mature A and B chains

The precursor account starts with proinsulin after its signal peptide has been removed. A B region, connecting region and A region are drawn as functional blocks with arbitrary widths. Processing removes the connecting peptide and cleavage-site residues. Mature insulin has separate A and B polypeptide chains linked by two inter-chain disulphide bonds; an additional internal A-chain disulphide link is noted but omitted from the simplified drawing. The figure is not a residue sequence, full three-dimensional structure or manufacturing protocol. The historical production of separate A and B chains is a distinct route described in the lesson.
The top account begins with proinsulin after signal-peptide removal and marks a connecting region between B and A regions. Processing removes the connecting peptide and cleavage-site residues. The lower drawing shows mature A and B chains with two inter-chain disulphide links; an additional internal A-chain link is noted but omitted. Block widths are arbitrary, and this is not a residue sequence or manufacturing protocol.

Open full-size diagram ↗

Correct a precursor-processing reversal

A proposed answer says mature insulin is formed by adding the C peptide between already mature A and B chains. That reverses the precursor account. Proinsulin contains the connecting region; maturation removes it while producing the mature chain arrangement. The diagram’s functional blocks should not be used to count residues or assume that the connecting region is retained in the final hormone.

The historical separate-chain route is another production account

The NCERT example describes expression of A and B chains separately, followed by recovery and combination with the appropriate disulphide arrangement. That historical route is distinct from saying that an ordinary bacterial host automatically performs every normal human precursor-processing step. Recombinant DNA presence, chain production, folding, processing and purified functional product are separate stages.

Choose the missing evidence for a recombinant product

An original construct is verified to contain the desired coding DNA, but the question asks whether a functional processed protein has been obtained. DNA verification alone cannot settle that. Evidence is still needed about expression and the relevant protein properties. A correct insert and a correctly folded, processed product are related achievements, but they are not the same measurement.

Amplification, detection and treatment are different aims

A method that amplifies a DNA region can help detect or study that region. A method that changes gene expression has a different molecular aim, and producing a recombinant protein is another. Do not equate detecting a target sequence with correcting it, or a conceptual textbook application with a guaranteed result for every organism. This guide explains curriculum mechanisms rather than individual treatment decisions.

Common mistakes: jump from a gene label to a universal outcome

Write construct→RNA or protein→target molecule or cell→observed effect. Mark where an inference needs extra evidence. Keep the C peptide out of the mature-chain account, and distinguish a historical separate-chain production route from precursor processing. Specificity and molecular level should remain visible in the explanation.

Try it: interpret unchanged genomic DNA detection

A target transcript decreases in a stated RNAi cleavage model, but a genomic DNA assay still detects the target sequence. Does that observation alone show the silencing failed?

Reveal the answer

No. The stated pathway reduces the RNA target without requiring removal of its DNA. Detection of genomic sequence and measurement of transcript abundance ask different questions. The actual amount and effect of silencing would need appropriate RNA/protein evidence.

Try it: distinguish the two mechanisms

Which description matches a protein-action route and which matches an RNA-silencing route: a Cry protein interacting with a susceptible gut target, or a guide-containing complex promoting target-mRNA cleavage?

Reveal the answer

The Cry description is the protein-action route. The guide-containing complex and mRNA cleavage describe the stated RNAi route. Both may begin with an engineered DNA context, but their acting molecules and immediate targets differ. Neither label alone establishes a universal response across organisms.

Come back tomorrow: trace the acting molecule

Explain why a target DNA assay can remain positive after transcript silencing. Then redraw the precursor and mature-chain distinction. Revisit the evidence stages in Biotechnology Principles and Processes, or connect heritable target responses to Evolution.

The action opens the broad applications pool rather than an RNAi-only or insulin-only set.

Sources and review

Technical review: Codex (automated), 24 October 2026. Core mechanisms were compared with the linked primary textbooks and university or government references. All diagrams, problem inputs and explanations are original. Numerical balances and diagram directions are checked separately. Independent human subject review is not claimed. These focused guides support the existing chapter catalogue; they do not claim complete current exam or syllabus coverage.

Choose your next chapter task

After an application error, state the acting molecule, immediate target and supported observation. Return to practice once the missing inference is explicit.

Open chapter practice and quiz choices →

Sources and reading
Type at least 2 characters or jump directly:
🔓

Save your learning progress

Sign in with a free account to save your practice answers and quiz results, then return to them when you revise.